Norman David Eansor is President at BIO-TECHNE Corp (TECH). They have made 9 open-market trades across 2 companies since 2018, most recently 2021-11-16.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $500K since 2021, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TECH | SELL | 2021-11-12 | 2021-11-16 | $504.00 | $26.6M | -4.9% | -8.5% | -18.0% |
| TECH | SELL | 2021-08-31 | 2021-09-02 | $503.07 | $1.5M | +3.9% | -5.6% | -9.4% |
| MRKR | BUY | 2021-03-16 | 2023-06-08 | $17.50 | $500K | +85.0% | +135.2% | +151.5% |
| TECH | SELL | 2021-02-05 | 2021-02-09 | $380.63 | $17.4M | -4.1% | -1.3% | +3.9% |
| TECH | SELL | 2020-05-28 | 2020-06-01 | $261.29 | $4.1M | -7.3% | +1.9% | -2.1% |
| TECH | SELL | 2020-05-21 | 2020-05-26 | $267.71 | $12.4M | -0.4% | +0.2% | -2.9% |
| TECH | SELL | 2020-03-04 | 2020-03-06 | $198.68 | $551K | -10.6% | +5.6% | +37.1% |
| TECH | SELL | 2019-06-12 | 2019-06-14 | $215.00 | $670K | -3.5% | +0.4% | -4.6% |
| TECH | SELL | 2018-05-04 | 2018-05-11 | $145.19 | $330K | +0.9% | +6.3% | +17.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.